Sunshine Biopharma (NASDAQ:SBFM) Posts Earnings Results, Misses Estimates By $9.94 EPS

Sunshine Biopharma (NASDAQ:SBFM) posted its quarterly earnings data on Tuesday. The company reported ($0.94) EPS for the quarter, missing analysts’ consensus estimates of $9.00 by ($9.94), Zacks reports. Sunshine Biopharma had a negative return on equity of 16.09% and a negative net margin of 12.07%. The company had revenue of $8.44 million during the quarter.

Sunshine Biopharma Stock Performance

Sunshine Biopharma stock opened at $2.68 on Thursday. The firm has a 50 day moving average price of $2.96 and a two-hundred day moving average price of $1.65. Sunshine Biopharma has a 52-week low of $2.42 and a 52-week high of $637.20. The firm has a market cap of $3.27 million, a price-to-earnings ratio of -0.01 and a beta of 1.38.

Sunshine Biopharma Company Profile

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.